跳至主要内容
临床试验/NCT01619436
NCT01619436已完成4 期

The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.

Federal University of Juiz de Fora1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
46
试验地点
1
主要终点
sedation

研究概览

简要总结

The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective CABG EF > 40% Sinus ritmy

排除标准

  • precordialgia emergency surgery combinated surgery not agreement

研究组 & 干预措施

clonidine

Active Comparator

clonidine 2 mg/kg IV

干预措施: Clonidine (Drug)

ringer lactato 1 ml

Placebo Comparator

Ringer lactato 1 ml IV as Placebo

干预措施: Ringer lactato (Drug)

结局指标

主要结局

sedation

时间窗: 2 years

Clonidine 2 mg/kg IV. assessment sedation with Ransay scale

次要结局

  • Glycemia(2 years)

研究者

发起方
Federal University of Juiz de Fora
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marcello F Salgado Filho, MD

Principal investigator

Federal University of Juiz de Fora

研究点 (1)

Loading locations...

相似试验